Sunday, 24 January 2021

Corning appoints new MD for India

26 May 2020 | News

Since joining the company last year, Pillai has been leading Corning’s Life Sciences and Pharmaceutical Technologies businesses

Corning Incorporated has announced that Sudhir Pillai has been appointed to the role of Managing Director for Corning India.

Sudhir, who most recently served as Commercial Director, Corning Life Sciences will be based in Gurugram, Haryana and will spearhead the company’s growth and operations in India and neighboring countries. He will also oversee Corning’s optical fibre manufacturing operations in Pune, India.

Thomas Appelt, President of Corning International said, “Sudhir has contributed significantly to the growth of the Corning Life Sciences business in India. Corning remains deeply committed to growing its customer base in India and helping to enhancing life in the communities in which we operate. Sudhir brings extensive experience in working in diverse locations and I am confident that he will drive Corning’s growth plans for India.”

“Since I joined Corning, I have been excited to be a part of Corning’s journey in India focused on growth avenues well aligned with the organization. Today, with this new responsibility, I am committed to taking the company’s vision forward and utilize my learnings in the field to ensure growth for the company in India, said Sudhir.

Sudhir brings with him close to twenty years of experience in increasing levels of leadership in organizations across diverse industry segments, including telecommunications. Since joining the company last year, he has been leading Corning’s Life Sciences and Pharmaceutical Technologies businesses in India and neighboring countries.

In his last role before joining Corning, Sudhir was the General Manager and Director of Honeywell Electrical Devices & Systems. Sudhir graduated in electronics science and completed his M.B.A. in marketing from University of Pune.

Sudhir replaces Amit Bansal, who has decided to pursue entrepreneurial opportunities after spending more than a decade with the company.



× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls